<DOC>
	<DOCNO>NCT02770560</DOCNO>
	<brief_summary>Thrombotic dysfunction common complication tunnel cuffed catheter ( TCC ) lead inadequate dialysis dose , need catheter replacement consequence progressive exclusion vascular site . Thrombolytic agent use therapeutic lock solution dissolve clot form around catheter lumen . There study optimal approach TCC-related thrombosis thrombolytic contain lock solution ( dose , number administration , time administration - intra interdialytic use ) . The primary objective retrospective study compare efficacy inter versus intradialytic Urokinase contain lock solution restoration TCC blood flow . The investigator also assess question multiple administration Urokinase efficient one single administration</brief_summary>
	<brief_title>Efficacy Urokinase Containing Locking Solutions Thrombotic Dysfunction Tunneled Hemodialysis Catheters</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Hemodialysis patient 18 year old , receive hemodialysis 1st May 2010 31st October 2014 via tunnel cuffed catheter Hemodialysis Unit Universitair Ziekenhuis Brussel Hospital . Patients young 18 year old Patients temporary dialysis catheter Patients never receive tunneled hemodialysis catheter period Patients n't medical file Universitair Ziekenhuis Brussel Hospital</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>